InsightfulValue
← Home

Astellas Pharma
Astellas Pharma

Pharma / Pharmaceuticals, Healthcare


📢 Press Releases

Date Press release
2025-05-29 20:15:00 Astellas Enters Exclusive License Agreement With Evopoint Biosciences For Xnw27011, A Novel Clinical-stage Antibody-drug Conjugate Targeting Cldn18.2
- agreement grants astellas exclusive worldwide rights (excluding china’s mainland, hong kong, macao and taiwan region) to develop and commercialize xnw27011 - - xnw27011 has demonstrated encouraging monotherapy efficacy in an ongoing phase 1/2 study of patients with solid tumors, including gastric cancer, gastroesophageal cancer and pancreatic cancer - - evopoint to receive a $130 million upfront payment and is eligible to receive up to $70 million near-term payments, and additional milestone payments associated with development, regulatory and commercialization milestones totaling up to $1. 34  billion, as well as royalties on net sales of xnw27011, if approved - tokyo and suzhou, china , may 29, 2025 /prnewswire/ -- astellas pharma inc. (tse: 4503, president and ceo: naoki okamura, ’astellas’) and evopoint biosciences (evopoint biosciences co., ltd.
2025-05-28 10:00:00 Astellas Announces Second Annual Patient Advocacy Organization (pao) Action Week™ To Empower Patients And Caregivers
Building on a successful inaugural year, the initiative sponsored by astellas’ patient centricity team continues to connect individuals with vital resources and support from patient advocacy organizations northbrook, ill. , may 28, 2025 /prnewswire/ -- astellas patient centricity is pleased to announce the second annual patient advocacy organization (pao) action week ™ taking place june 9-13, 2025.
2025-05-21 11:00:00 Astellas And Mbc Biolabs Announce The 2025 Astellas Future Innovator Prize Awarded To Deepseq.ai & Serna Bio
Both companies have earned a year-long opportunity for access to a distinguished life-science incubator in san francisco along with the invaluable expertise provided by astellas to advance their research endeavors award helps biotech startups accelerate early research efforts northbrook, ill. , may 21, 2025 /prnewswire/ -- astellas pharma u.s. inc. (head of commercial: mike petroutsas, ’astellas’), and mbc biolabs, a premier launchpad for early-stage life-science companies, today announced deepseq.ai, inc. & serna bio as the winners of the astellas sponsored future innovator prize at mbc biolabs.
2025-05-01 09:00:00 Astellas To Present New Data In Geographic Atrophy At Upcoming Ophthalmology Annual Congresses
Arvo and rwc abstracts feature analyses on biomarkers, mechanism of disease, patient experience and other data from izervay ™  (avacincaptad pegol intravitreal solution) pivotal studies tokyo , may 1, 2025 /prnewswire/ -- astellas pharma inc. (tse: 4503, president and ceo: naoki okamura, ’astellas’), maker of izervay™ (avacincaptad pegol intravitreal solution), a c5 inhibitor for the treatment of geographic atrophy (ga)*, will highlight new data that enhances continued understanding of the science of ga, and the experience of patients living with the progressive disease at the association for research in vision and ophthalmology annual meeting (arvo), may 4-8, salt lake city, utah, and retina world congress (rwc), may 8-11, fort lauderdale, florida. the data comprises nine abstracts, including two oral presentations, featuring analyses on biomarkers, patient experience, mechanism of disease and other insights from the gather phase 3 studies of izervay for the treatment of ga secondary to age-related macular degeneration (amd).
2025-03-24 11:48:00 Singlera Genomics Presented Non-invasive Testicular Toxicity Detection With Astellas At 2025 Sot Meeting
San diego, march 24, 2025 (globe newswire) -- singlera genomics presented results showing a refined approach to detect drug-induced testicular toxicity using singlera’s cell-free dna methylation technology with astellas during the sot 2025 annual meeting.
2025-02-27 10:00:00 QXN0ZWxsYX MgQW5kIE1i YyBCaW9sYW JzIEFubm91 bmNlIFRoZS BTaXh0aCBB bm51YWwgQX N0ZWxsYXMg RnV0dXJlIE lubm92YXRv ciBQcml6ZQ ==
QXdhcmRlZX Mgd2luIGEg eWVhciBvZi BhY2Nlc3Mg dG8gYSBwcm VzdGlnaW91 cyBsaWZlLX NjaWVuY2Ug aW5jdWJhdG 9yIGluIHNh biBmcmFuY2 lzY28gYW5k IHRvwqBhc3 RlbGxhcyBl eHBlcnRpc2 UgdG8gZnVy dGhlciB0aG VpciByZXNl YXJjaCBhd2 FyZCBoZWxw cyBiaW90ZW NoIHN0YXJ0 LXVwcyBhY2 NlbGVyYXRl IGVhcmx5IG RydWcgZGlz Y292ZXJ5IG FuZCByZXNl YXJjaCBlZm ZvcnRzIG5v cnRoYnJvb2 ssIGlsbC4g LCBmZWIuID I3LCAyMDI1 IC9wcm5ld3 N3aXJlLyAt LSBhc3RlbG xhcyBwaGFy bWEgdS5zLi BpbmMuICho ZWFkIG9mIG NvbW1lcmNp YWw6IG1pa2 UgcGV0cm91 dHNhcywg4o CZYXN0ZWxs YXPigJkpLC BhbmQgbWJj IGJpb2xhYn MsIGEgcHJl bWllciBsYX VuY2hwYWQg Zm9yIGVhcm x5LXN0YWdl IGxpZmUtc2 NpZW5jZSBj b21wYW5pZX MsIHRvZGF5 IGFubm91bm NlZCB0aGVp ciBjb2xsYW JvcmF0aW9u IG9uIHRoZS Bhc3RlbGxh cyBmdXR1cm UgaW5ub3Zh dG9yIHByaX plLg==
2025-02-12 18:32:00 VS5zLiBGZG EgQXBwcm92 ZXMgRXhwYW 5kZWQgTGFi ZWwgRm9yIE FzdGVsbGFz 4oCZIEl6ZX J2YXnihKIg KGF2YWNpbm NhcHRhZCBQ ZWdvbCBJbn RyYXZpdHJl YWwgU29sdX Rpb24pIEZv ciBHZW9ncm FwaGljIEF0 cm9waHk=
SXplcnZheS Bkb3Npbmcg YXBwcm92ZW QgYmV5b25k IDEyIG1vbn Roc8KgIHRv a3lvICwgZm ViLiAxMiwg MjAyNSAvcH JuZXdzd2ly ZS8gLS0gYX N0ZWxsYXMg cGhhcm1hIG luYy4gKHRz ZTogNDUwMy wgcHJlc2lk ZW50IGFuZC BjZW86IG5h b2tpIG9rYW 11cmEsIOKA mWFzdGVsbG Fz4oCZKSB0 b2RheSBhbm 5vdW5jZWQg dGhlIHUucy 4gZm9vZCBh bmQgZHJ1Zy BhZG1pbmlz dHJhdGlvbi AoZmRhKSBh cHByb3ZlZC BleHBhbmRl ZCB1LnMuIH ByZXNjcmli aW5nIGluZm 9ybWF0aW9u IGZvciBpem VydmF54oSi IChhdmFjaW 5jYXB0YWQg cGVnb2wgaW 50cmF2aXRy ZWFsIHNvbH V0aW9uKSBm b3IgdGhlIH RyZWF0bWVu dCBvZiBnZW 9ncmFwaGlj IGF0cm9waH kgKGdhKSBz ZWNvbmRhcn kgdG8gYWdl LXJlbGF0ZW QgbWFjdWxh ciBkZWdlbm VyYXRpb24g KGFtZCkuIG FzIGEgcmVz dWx0LCBpem VydmF5IGlz IG5vdyBhcH Byb3ZlZCB3 aXRob3V0IG EgbGltaXRh dGlvbiBvbi BkdXJhdGlv biBvZiBkb3 NpbmfigJRw cm92aWRpbm cgcGh5c2lj aWFucyBhbm QgcGF0aWVu dHMgd2l0aC BncmVhdGVy IGZsZXhpYm lsaXR5IHdo ZW4gbWFuYW dpbmcgZ2Eu
2025-02-05 03:59:00 QXN0ZWxsYX MgU3VibWl0 cyBOZXcgRH J1ZyBBcHBs aWNhdGlvbi BGb3IgQ29u ZGl0aW9uYW wgQXBwcm92 YWwgT2YgQX ZhY2luY2Fw dGFkIFBlZ2 9sIEZvciBH ZW9ncmFwaG ljIEF0cm9w aHkgSW4gSm FwYW4=
LSBtaW5pc3 RyeSBvZiBo ZWFsdGgsIG xhYm91ciBh bmQgd2VsZm FyZSB0byBl dmFsdWF0ZS BhY3AgYXMg cG90ZW50aW FsIGZpcnN0 IGFuZCBvbm x5IHRyZWF0 bWVudCBmb3 IgcGF0aWVu dHMgd2l0aC BnZW9ncmFw aGljIGF0cm 9waHkgKGdh KSBzZWNvbm RhcnkgdG8g YWdlLXJlbG F0ZWQgbWFj dWxhciBkZW dlbmVyYXRp b24gKGFtZC kgaW4gamFw YW4gLSB0b2 t5byAsIGZl Yi4gNSwgMj AyNSAvcHJu ZXdzd2lyZS 8gLS0gYXN0 ZWxsYXMgcG hhcm1hIGlu Yy4gKHRzZT ogNDUwMykg KHByZXNpZG VudCBhbmQg Y2VvOiBuYW 9raSBva2Ft dXJhLMKg4o CZYXN0ZWxs YXPigJkpIH RvZGF5IGFu bm91bmNlZC B0aGUgc3Vi bWlzc2lvbi BvZiBhIG5l dyBkcnVnIG FwcGxpY2F0 aW9uIChuZG EpIHRvIGph cGFu4oCZcy BtaW5pc3Ry eSBvZiBoZW FsdGgsIGxh Ym91ciBhbm Qgd2VsZmFy ZSAobWhsdy kgZm9yIGNv bmRpdGlvbm FsIGFwcHJv dmFsIG9mIG F2YWNpbmNh cHRhZCBwZW dvbCBpbnRy YXZpdHJlYW wgc29sdXRp b24gKGFjcC ksIGEgc3lu dGhldGljIG FwdGFtZXIg dGhhdCBpbm hpYml0cyB0 aGUgY29tcG xlbWVudCBj NSBwcm90ZW luLCBmb3Ig dGhlIHRyZW F0bWVudCBv ZiBnYSBzZW NvbmRhcnkg dG8gYW1kLi BpZiBhcHBy b3ZlZCwgYW NwIGhhcyB0 aGUgcG90ZW 50aWFsIHRv IGJlY29tZS B0aGUgZmly c3QgYW5kIG 9ubHkgZ2Eg dHJlYXRtZW 50IGF2YWls YWJsZSBpbi BqYXBhbi4=
2025-02-04 01:30:00 QXN0ZWxsYX MgTWFrZXMg QW5ub3VuY2 VtZW50IEFi b3V0IE1hbm FnZW1lbnQg U3RydWN0dX Jl
VG9reW8gLC BmZWIuIDQs IDIwMjUgL3 BybmV3c3dp cmUvIC0tIG FzdGVsbGFz IHBoYXJtYS BpbmMuICh0 c2U6IDQ1MD MswqBwcmVz aWRlbnQgYW 5kIGNlbzog bmFva2kgb2 thbXVyYSzC oOKAmWFzdG VsbGFz4oCZ KSB0b2RheS Bhbm5vdW5j ZWQgdGhhdM KgdGhlIGZv bGxvd2luZy BjaGFuZ2Vz IHRvIGl0cy BtYW5hZ2Vt ZW50IHN0cn VjdHVyZSBl ZmZlY3Rpdm UgYXByaWwg MSwgMjAyNS 4gcmVnYXJk aW5nIHRoZS BjaGFuZ2Ug cyBpbiBtYW 5hZ2VtZW50 IHN0cnVjdH VyZSBhc3Rl bGxhcyBhaW 1zIHRvIGNy ZWF0ZSBhbm QgZGVsaXZl ciDigJl2YW x1ZeKAmSBm b3IgcGF0aW VudHMu
2024-12-25 20:30:00 QXhjZWxlYW QgRGRwIEVu dGVycyBJbn RvIERydWcg RGlzY292ZX J5IFNlcnZp Y2UgQWdyZW VtZW50IFdp dGggQXN0ZW xsYXMgRm9y IFRhcmdldG VkIFByb3Rl aW4gRGVncm FkZXJz
VG9reW8tLS hidXNpbmVz cyB3aXJlKS 0tICNhc3Rl bGxhcy0tYX hjZWxlYWQg ZGRwIGVudG VycyBpbnRv IGRydWcgZG lzY292ZXJ5 IHNlcnZpY2 UgYWdyZWVt ZW50IHdpdG ggYXN0ZWxs YXMgZm9yIH RhcmdldGVk IHByb3RlaW 4gZGVncmFk ZXJzLg==
2024-12-05 08:49:00 QXN0ZWxsYX MgQW5kIERy LiBKZW4gQX NodG9uIExh dW5jaCBcIm Nvb2xlciBN b21lbnRzXC IgVG8gU3Bv dGxpZ2h0IE 1lbm9wYXVz YWwgSG90IE ZsYXNoZXMg QW5kIEVtcG 93ZXIgV29t ZW4gVG8gQW R2b2NhdGUg Rm9yIFRoZW 1zZWx2ZXM=
4oCZY29vbG VyIG1vbWVu dHPigJkgZW R1Y2F0ZXMg YW5kIGVtcG 93ZXJzIHdv bWVuIGluIG 1pZGxpZmUg dG8gc3BlYW sgdXAgZm9y IHRoZW1zZW x2ZXMgYW5k IGNlbGVicm F0ZSB0aGlz IG5hdHVyYW wgY2hhbmdl IGluIHRoZW lyIGxpdmVz LiBub3J0aG Jyb29rLCBp bGwu
2024-11-20 13:00:00 QXN0ZWxsYX MgQW5ub3Vu Y2VzIERlc2 VydCBPYXNp cyBIZWFsdG hjYXJlIEFz IEZpcnN0IE hlYWx0aCBT eXN0ZW0gVG 8gSW1wbGVt ZW50IERpZ2 l0aXZh4oSi IEZvciBIZW FydCBGYWls dXJlIE1hbm FnZW1lbnQ=
U2FuIGZyYW 5jaXNjbyAs IG5vdi4gMj AsIDIwMjQg L3BybmV3c3 dpcmUvIC0t IGFzdGVsbG FzIHBoYXJt YSB1LnMuLC BpbmMuIChw cmVzaWRlbn Q6IG1pa2Ug cGV0cm91dH Nhcywg4oCZ YXN0ZWxsYX PigJkpIHRv ZGF5IGFubm 91bmNlZCB0 aGF0IGl0IG hhcyBlbnRl cmVkIGludG 8gYW4gYWdy ZWVtZW50IH dpdGggZGVz ZXJ0IG9hc2 lzIGhlYWx0 aGNhcmUgKG RvaGMpLCBh IG1lbWJlci BvZiBoZXJp dGFnZSBwcm 92aWRlciBu ZXR3b3JrLM KgdG8gcGls b3QgZGlnaX RpdmHihKIs IGEgbm9uLW ludmFzaXZl IGRpZ2l0YW wgaGVhbHRo IHNvbHV0aW 9uIGZvciB0 aGUgbWFuYW dlbWVudCBv ZiBoZWFydC BmYWlsdXJl IHBhdGllbn RzLiBpbiB0 aGUgbmV4dC BmZXcgd2Vl a3MsIGVsaW dpYmxlIHBh dGllbnRzIH JlY2Vpdmlu ZyBjYXJlIH dpdGjCoGRv aGPCoHdpbG wgYmVnaW4g dXNpbmcgZG lnaXRpdmEg YXMgYSBuZX cgbWV0aG9k IGZvciBtYW 5hZ2luZyB0 aGVpciBoZW FydCBoZWFs dGggd2hpbG Ugd29ya2lu ZyBpbiBwYX J0bmVyc2hp cCB3aXRoIH RoZWlyIGhl YWx0aGNhcm UgdGVhbS4=
2024-10-10 03:00:00 QXN0ZWxsYX MgVG8gUHJl c2VudCBWZW 96YeKEoiAo ZmV6b2xpbm V0YW50KSBE YXRhIEF0IE ltcyBXb3Js ZCBDb25ncm VzcyBPbiBN ZW5vcGF1c2 U=
VG9reW8gLC BvY3QuIDEw LCAyMDI0IC 9wcm5ld3N3 aXJlLyAtLc KgYXN0ZWxs YXMgcGhhcm 1hIGluYy4g KHRzZTogND UwMywgcHJl c2lkZW50IG FuZCBjZW86 IG5hb2tpIG 9rYW11cmEs IOKAmWFzdG VsbGFz4oCZ KSBhbm5vdW 5jZWQgdGhh dCB2ZW96Ye KEosKgKGZl em9saW5ldG FudCkqLCBp dHMgZmlyc3 QtaW4tY2xh c3MgdHJlYX RtZW50IGZv ciBtb2Rlcm F0ZSB0byBz ZXZlcmUgdm Fzb21vdG9y IHN5bXB0b2 1zICh2bXMp IGFzc29jaW F0ZWQgd2l0 aCBtZW5vcG F1c2UsIHdp bGwgYmUgZm VhdHVyZWQg aW4gZm91ci BvcmFsIGFu ZCB0d28gcG 9zdGVyIHBy ZXNlbnRhdG lvbnMgZHVy aW5nIHRoZS BpbnRlcm5h dGlvbmFsIG 1lbm9wYXVz ZSBzb2NpZX R5IChpbXMp IDE5dGggd2 9ybGQgY29u Z3Jlc3Mgb2 4gbWVub3Bh dXNlIGluIG 1lbGJvdXJu ZSwgYXVzdH JhbGlhLCBv Y3RvYmVyID E5LTIyLiB2 bXMsIGFsc2 8ga25vd24g YXMgaG90IG ZsYXNoZXMg YW5kL29yIG 5pZ2h0IHN3 ZWF0cywgYX JlIGNvbW1v biBzeW1wdG 9tcyBvZiBt ZW5vcGF1c2 Uu
2024-10-08 09:27:00 QXN0ZWxsYX MgQW5kIEF2 aWFkb2Jpby BBbm5vdW5j ZSBFeGNsdX NpdmUgT3B0 aW9uIEFuZC BMaWNlbnNl IEFncmVlbW VudCBGb3Ig R2VuZSBUaG VyYXB5IEF2 Yi0xMDEgVG FyZ2V0aW5n IEZyb250b3 RlbXBvcmFs IERlbWVudG lhIEFuZCBP dGhlciBJbm RpY2F0aW9u cw==
QXN0ZWxsYX MgcmVjZWl2 ZXMgYW4gZX hjbHVzaXZl IG9wdGlvbi B0byBsaWNl bnNlIGF2Yi 0xMDEsIGFu IGludmVzdG lnYXRpb25h bCwgYWF2LW Jhc2VkIGdl bmUgdGhlcm FweSBpbiBw aGFzZSAxLz IgZGV2ZWxv cG1lbnTCoC BhdmlhZG9i aW8gcmVjZW l2ZXMgJDIw IG1pbGxpb2 4gZXF1aXR5 IGludmVzdG 1lbnQsIHVw IHRvICQzMC BtaWxsaW9u IGluIHVwZn JvbnQgcGF5 bWVudHMgYW 5kIGlzIGVs aWdpYmxlIH RvIHJlY2Vp dmUgdXAgdG 8gJDIuMTgg YmlsbGlvbi BpbiBsaWNl bnNlIGZlZX MgYW5kIG1p bGVzdG9uZS BwYXltZW50 cyBwbHVzIH JveWFsdGll cyBpZiBhc3 RlbGxhcyBl eGVyY2lzZX MgaXRzIG9w dGlvbiBsb2 5kb24gYW5k IHRva3lvIC wgb2N0LiA4 LCAyMDI0IC 9wcm5ld3N3 aXJlLyAtLS BhdmlhZG9i aW8gbHRkLi Ao4oCZYXZp YWRvYmlv4o CZKSBhbmQg YXN0ZWxsYX MgcGhhcm1h IGluYy4gKH RzZTogNDUw MywgcHJlc2 lkZW50IGFu ZCBjZW86IG 5hb2tpIG9r YW11cmEsIO KAmWFzdGVs bGFz4oCZKS B0b2RheSBh bm5vdW5jZW QgYW4gZXhj bHVzaXZlIG 9wdGlvbiBh bmQgbGljZW 5zZSBhZ3Jl ZW1lbnQgZm 9yIGF2Yi0x MDEsIGFuIG ludmVzdGln YXRpb25hbC wgYWF2LWJh c2VkIGdlbm UgdGhlcmFw eSBpbiBwaG FzZSAxLzIg ZGV2ZWxvcG 1lbnQgZm9y IHBhdGllbn RzIHdpdGgg ZnJvbnRvdG VtcG9yYWwg ZGVtZW50aW Egd2l0aCBw cm9ncmFudW xpbiBtdXRh dGlvbnMgKG Z0ZC1ncm4p Lg==
2024-10-01 16:24:00 U2luZ2xlcm EgR2Vub21p Y3MgQW5kIE FzdGVsbGFz IFByZXNlbn QgTWV0aHls YXRpb24tYm FzZWQgT3Jn YW4gVG94aW NpdHkgRGV0 ZWN0aW9uIE F0IDIwMjQg SnNvdCBBbm 51YWwgTWVl dGluZw==
U2FuIGRpZW dvLS0oYnVz aW5lc3Mgd2 lyZSktLXNp bmdsZXJhIG dlbm9taWNz IGFuZCBhc3 RlbGxhcyBw aGFybWEgcH Jlc2VudGVk IHJlc3VsdH MgZHVyaW5n IHRoZSBqc2 90IDIwMjQg YW5udWFsIG 1lZXRpbmcg ZGVtb25zdH JhdGluZyB0 aGF0IGRydW ctaW5kdWNl ZCB0ZXN0aW N1bGFyIHRv eGljaXR5IG NhbiBiZSBk ZXRlY3RlZC B1c2luZyBj ZWxsLWZyZW UgZG5hIG1l dGh5bGF0aW 9uIGluIGFu aW1hbCBtb2 RlbHMuIHNp bmdsZXJh4o CZcyBtdGl0 YW4gdGVjaG 5vbG9neSBo YXMgcHJldm lvdXNseSBi ZWVuIHV0aW xpemVkIHRv IG5vbi1pbn Zhc2l2ZWx5 IGRldGVjdC BjYW5jZXIg bWV0aHlsYX Rpb24gc2ln bmFscyBpbi BibG9vZCBm b3VyIHllYX JzIHByaW9y IHRvIHBhdG llbnRzIHNo b3dpbmcgc3 ltcHRvbXMu IGFzdGVsbG FzIHByZXNl bnRlZCB0aG UgcmVzdWx0 cyBvZiBhbm ltYWwgbW9k ZWwgZXhwZX JpbWVudHMg ZGVtb25zdH JhdGluZyB0 aGF0IHRoZX NlIHRlY2hu b2xvZ2llLg ==
Astellas Pharma

📰 Browse additional press releases for Astellas Pharma!

Sign up for free or log in

💡 Learn smarter stock picks with "The Checklist Value Investor — A Smarter Way to Pick Stocks"

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal